Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions
Authors:
- Michel BurnierMBMichel Burnier
- Marie Paule SchneiderMSMarie Paule Schneider
- Arnaud ChioléroACArnaud Chioléro
- Claire Lise Fallab StubiCSClaire Lise Fallab Stubi
- Hans R. BrunnerHBHans R. Brunner
- 1 February 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 19 (2) , 335-341
Abstract
Incomplete compliance is one of several possible causes of uncontrolled hypertension. Yet, non-compliance remains largely unrecognized and is falsely interpreted as treatment resistance, because it is difficult to confirm or exclude objectively. The goal of this study was to evaluate the potential benefits of electronic monitoring of drug compliance in the management of patients with resistant hypertension. Forty-one hypertensive patients resistant to a three-drug regimen (average blood pressure 156/106 ± 23/11 mmHg, mean ± SD) were studied prospectively. They were informed that for the next 2 months, their presently prescribed drugs would be provided in electronic monitors, without any change in treatment, so as to provide the treating physician with a measure of their compliance. Thereafter, patients were offered the possibility of prolonging the monitoring of compliance for another 2 month period, during which treatment was adapted if necessary. Monitoring of compliance alone was associated with a significant improvement of blood pressure at 2 months (145/97 ± 20/15 mmHg, P < 0.01). During monitoring, blood pressure was normalized (systolic < 140 mmHg or diastolic < 90 mmHg) in one-third of the patients and insufficient compliance was unmasked in another 20%. When analysed according to tertiles of compliance, patients with the lowest compliance exhibited significantly higher achieved diastolic blood pressures ( P = 0.04). In 30 patients, compliance was monitored up to 4 months and drug therapy was adapted whenever necessary. In these patients, a further significant decrease in blood pressure was obtained (from 150/100 ± 18/15 to 143/94 ± 22/11 mmHg, P = 0.04/0.02). These results suggest that objective monitoring of compliance using electronic devices may be a useful step in the management of patients with refractory hypertension, as it enables physicians to take rational decisions based on reliable and objective data of drug compliance and hence to improve blood pressure control.Keywords
This publication has 22 references indexed in Scilit:
- Inadequate Management of Blood Pressure in a Hypertensive PopulationNew England Journal of Medicine, 1998
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- Blood pressure screening, management and control in EnglandJournal Of Hypertension, 1998
- Prognostic Value of Ambulatory Blood Pressure Monitoring in Refractory HypertensionHypertension, 1998
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of internal medicine (1960), 1997
- Hypertension awareness, treatment and control in the community: is the ‘rule of halves’ still valid?Journal of Human Hypertension, 1997
- Prevalence of Hypertension in the US Adult PopulationHypertension, 1995
- Refractory HypertensionNew England Journal of Medicine, 1992
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990
- Role of Blood Pressure in the Development of Congestive Heart FailureNew England Journal of Medicine, 1972